Clinical trial
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
NCT00443430
Study timeline
Study start (unknown)2007-05-01Date precision: month
Registry last updated2013-05-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Juvenile Chronic Polyarthritisunresolved
Juvenile Idiopathic Arthritisunresolved
Juvenile Rheumatoid Arthritisunresolved
Interventions
methotrexateDRUG · verified · RxNorm: methotrexate
Sponsors & collaborators
Seattle Children's Hospitallead sponsor
Amgencollaborator
Mapped research locations
BostonMassachusetts, United States1DallasTexas, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1ClevelandOhio, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1Oklahoma CityOklahoma, United States1Salt Lake CityUtah, United States1The BronxNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00443430 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.